Old Web
English
Sign In
Acemap
>
authorDetail
>
Huibin Yue
Huibin Yue
AbbVie
Medicine
Pathology
Cancer research
Antibody-drug conjugate
Monomethyl auristatin E
2
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors.
2021
Molecular Cancer Therapeutics
Michael Gordon
John Nemunaitis
Minal A. Barve
Zev A. Wainberg
Erika Hamilton
Ramesh K. Ramanathan
George W. Sledge
Huibin Yue
Susan E. Morgan-Lappe
Martha Elizabeth Blaney
Sreeneeranj Kasichayanula
Monica Motwani
Lan Wang
Louie Naumovski
John H. Strickler
Show All
Source
Cite
Save
Citations (0)
First-in-human phase 1 study of ABBV-085, an antibody-drug conjugate (ADC) targeting LRRC15, in sarcomas and other advanced solid tumors.
2019
Journal of Clinical Oncology
George D. Demetri
Jason J. Luke
Antoine Hollebecque
John D. Powderly
Alexander I. Spira
Vivek Subbiah
Dominic W. Lai
Huibin Yue
Sreeneeranj Kasichayanula
Scott Gulbranson
James W. Purcell
Melinda Myzak
Randy Robinson
Victor M. Villalobos
Anthony W. Tolcher
Show All
Source
Cite
Save
Citations (7)
1